If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

While the exact cause of asthma is unknown, certain genetic factors can increase the risk of developing the disease.

Although cost-related asthma treatment nonadherence has declined in the US, nearly 1 in 6 patients are still nonadherent due to cost concerns.

A study reveals that shape-shifting immune cells, intermediate ILC2s, may contribute to severe asthma and resistance to ...

Is there a natural cure for asthma? Asthma is a chronic lung condition characterised by recurrent attacks of breathlessness, often accompanied by wheezing. Asthma is due to inflammation in the air ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- A set of chameleon-like immune cells could be contributing to severe asthma in ...

Researchers at McMaster University have made an important discovery in the field of asthma research, identifying a new ...

Jan. 21, 2025 — A new study found that pregnant women are regularly excluded from clinical drug trials that test for safety, raising concerns for the efficacy of these medications for maternal ...

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

Impacting millions of children in the U.S. alone, asthma can be particularly problematic to diagnose with specificity — ...

A simple, noninvasive nasal swab identified a predominance of T2-low asthma subtypes in racial and ethnic minority pediatric ...

A recent study has identified a new non-invasive nasal swab test that could change asthma treatment for children, which can ...